Pregio Pharma Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
as on 02-07-2024
- Paid Up Capital ₹ 12.32 Cr
as on 02-07-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.34 Cr
as on 02-07-2024
- Satisfied Charges ₹ 8.40 Cr
as on 02-07-2024
- Revenue 18.61%
(FY 2023)
- Profit 21.40%
(FY 2023)
- Ebitda 8.44%
(FY 2023)
- Net Worth 7.88%
(FY 2023)
- Total Assets -14.72%
(FY 2023)
About Pregio Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 12.32 Cr.
The company currently has active open charges totaling ₹6.34 Cr. The company has closed loans amounting to ₹8.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Pregio Pharma Private Limited India are Ranganathan Kuppan as CFO and Viswanathan Palaniappan as Company Secretary. Muthuvelayudham Sivakumar and Sasikumar serve as directors at the Company.
- CIN/LLPIN
U24297TN2011PTC079939
- Company No.
079939
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Pregio Pharma Private Limited offer?
Pregio Pharma Private Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Azithromycin Tablets, Cardiovascular Drugs & Medication, Kidney Drugs, Antidepressant & Anti Anxiety Medicines, Antidepressant Tablet, Antipyretic Medication, Paracetamol Tablets, Common Disease Medicines, Psoriasis Ointment.
Who are the key members and board of directors at Pregio Pharma?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muthuvelayudham Sivakumar  | Managing Director | 30-Mar-2011 | Current |
| Ranganathan Kuppan | CFO | 01-Sep-2023 | Current |
| Viswanathan Palaniappan | Company Secretary | 16-Aug-2023 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sasikumar | Director | 28-Oct-2016 | Current |
Financial Performance of Pregio Pharma.
Pregio Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.61% increase. The company also saw a substantial improvement in profitability, with a 21.4% increase in profit. The company's net worth moved up by a moderate rise of 7.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pregio Pharma?
In 2023, Pregio Pharma had a promoter holding of 11.13% and a public holding of 88.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 21 Nov 2023 | ₹0.80 M | Open |
Indian Overseas Bank Creation Date: 28 Jul 2023 | ₹6.26 Cr | Open |
The South Indian Bank Limited Creation Date: 31 Dec 2019 | ₹4.42 Cr | Satisfied |
How Many Employees Work at Pregio Pharma?
Unlock and access historical data on people associated with Pregio Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pregio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pregio Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
